These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26768739)

  • 21. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study.
    Mangiacapra F; Colaiori I; Ricottini E; Balducci F; Creta A; Demartini C; Minotti G; Di Sciascio G
    Clin Res Cardiol; 2017 Jan; 106(1):69-75. PubMed ID: 27520989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM; Vitale C; Volterrani M
    Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmic effects of ivabradine in patients with coronary artery disease.
    Murat SN; Orcan S; Akdemir R; Dogan M; Kara E; Balci M
    Clin Invest Med; 2009 Oct; 32(5):E322-6. PubMed ID: 19796572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.
    Zarifis J; Grammatikou V; Kallistratos M; Katsivas A;
    Clin Cardiol; 2015 Dec; 38(12):725-32. PubMed ID: 26782939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.
    Cacciapuoti F
    Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):98-102. PubMed ID: 26944071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ivabradine, coronary artery disease, and heart failure: beyond rhythm control.
    Scicchitano P; Cortese F; Ricci G; Carbonara S; Moncelli M; Iacoviello M; Cecere A; Gesualdo M; Zito A; Caldarola P; Scrutinio D; Lagioia R; Riccioni G; Ciccone MM
    Drug Des Devel Ther; 2014; 8():689-700. PubMed ID: 24940047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ivabradine: from molecular basis to clinical effectiveness.
    Riccioni G
    Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ivabradine on structural and functional changes of myocardium and NT-proBNP levels in patients with stable coronary heart disease after coronary stenting.
    Kupnovytska IH; Romanyshyn NM; Fitkovska IP; Gubina NV; Krasnopolsky SZ; Klymenko VI; Kalugina SM
    Wiad Lek; 2024; 77(4):800-810. PubMed ID: 38865640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know?
    Lopatin YM; Vitale C
    Int J Cardiol; 2016 Dec; 224():145-148. PubMed ID: 27657463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A; de Silva R
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):407-417. PubMed ID: 27475447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population.
    ; Ferrari R; Ford I; Fox K; Steg PG; Tendera M
    Cardiology; 2008; 110(4):271-82. PubMed ID: 18595216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.
    Zarifis J; Grammatikou V; Kallistratos M; Katsivas A
    Angiology; 2017 Jan; 68(1):10-18. PubMed ID: 26960667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine: the hope for a good treatment of ischemic heart disease.
    Riccioni G
    Curr Med Chem; 2013; 20(14):1817-23. PubMed ID: 23394554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R; Ceconi C
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heart rate modulation in stable ischemic heart disease: what we have learned from the SIGNIFY study?].
    Perna GP; Battistoni I; Angelini L
    G Ital Cardiol (Rome); 2015 Mar; 16(3):155-60. PubMed ID: 25837459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.
    Niccoli G; Borovac JA; Vetrugno V; Camici PG; Crea F
    Int J Cardiol; 2017 Jun; 236():107-112. PubMed ID: 28256323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
    Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
    Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.